查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1908485

腦機介面市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途和細分市場預測（2026-2033 年）

Brain Computer Interface Market Size, Share & Trends Analysis Report By Product, Application, End Use And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

腦機介面市場概覽

據估計，到 2025 年，全球腦機介面 (BCI) 市場總潛在市場規模 (TAM) 將達到 1,682.7 億美元，從 2026 年到 2033 年，複合年成長率 (CAGR) 為 1.52%。

研究表明，腦機介面 (BCI) 能為肌萎縮側索硬化症 (ALS)、脊髓損傷和中風等疾病患者恢復運動和溝通能力提供更大的信心。

同時，非腦機介面（non-BCI）的可用市場規模預計在2025年達到3.9759億美元，並預計在2026年至2033年間以8.73%的複合年成長率成長。主要市場促進因素包括需要義肢假體的疾病增加、全球老化人口的不斷成長，以及癱瘓患者能夠進行溝通和行動的技術進步。此外，非腦機介面在家庭控制系統、虛擬遊戲、軍事通訊等領域的日益普及，也提升了其市場適用性並推動了市場成長。

腦機介面（BCI）技術主要應用於醫學研究領域，幫助身心障礙者控制義肢並恢復溝通能力。這些系統使用佩戴在頭皮上或植入大腦的電極來收集和解讀神經訊號，並將其轉換為外部裝置的指令。近年來，BCI技術的進步使其更加普及、經濟實惠且用途廣泛。市面上已有Muse和NeuroSky等消費級BCI設備。這些頭戴式裝置採用無線乾電極，無需導電凝膠，因此配戴舒適，即使長時間使用也不會感到不適。因此，此類產品的市場供應正在推動市場成長。

神經退化性疾病的日益增加是推動腦機介面（BCI）市場成長的關鍵因素。阿茲海默症、帕金森氏症、肌萎縮側索硬化症（ALS）和多發性硬化症（MS）等神經退化性疾病的特徵是神經細胞進行進行性退化，導致大腦和神經系統受影響區域的功能逐漸喪失。

根據世界衛生組織的報告，到2030年，全球約有8,200萬人將受到失智症的影響，預計到2050年這一數字將達到1.52億，這表明未來幾年對腦機介面（BCI）的潛在需求龐大。這些疾病會嚴重影響患者的運動功能、溝通能力和整體生活品質。隨著世界人口老化的加劇，這些疾病的發病率預計將會上升，因此迫切需要創新解決方案來幫助控制症狀、恢復喪失的功能並提高患者的生活品質。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 腦機介面市場變數、趨勢與範圍

  • 市場動態
  • 腦機介面市場分析工具
    • 產業分析：波特五力模型
    • PESTEL 分析
    • 腦機介面技術的臨床測試流程
    • 用例研究

第4章：腦機介面（BCI）按應用分類的總潛在市場規模（TAM）、估算與趨勢分析

  • 按應用領域分類的市場佔有率（2025 年和 2033 年）
  • 全球腦機介面市場：按應用領域分類的展望
  • 肌萎縮側索硬化症（ALS）
  • 中風
  • 脊髓損傷
  • 多發性硬化症患者
  • 腦性麻痹
  • 截肢
  • 癲癇
  • 憂鬱症
  • 帕金森氏症

第5章 腦機介面市場：按應用分類的估算與趨勢分析

  • 按應用領域分類的市場佔有率（2025 年和 2033 年）
  • 全球腦機介面市場：按應用領域分類的展望
  • 醫療保健
    • 恢復受損功能
    • 腦功能修復
  • 智慧家庭控制
  • 通訊與控制
  • 娛樂遊戲

第6章：腦機介面市場：最終用途、預測與趨勢分析

  • 按最終用途分類的市場佔有率（2025 年和 2033 年）
  • 全球腦機介面市場：依最終用途分類的展望
  • 醫療保健
  • 教育與研究
  • 其他

第7章 腦機介面市場依地區、估算及趨勢分析及類型分類

  • 區域市場佔有率分析（2025 年和 2033 年）
  • 區域市場概覽
  • 全球區域市場概覽
  • 市場規模及預測趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 主要企業市佔率和地位分析（2025 年）
  • 公司簡介
    • Medtronic
    • G.Tec medical engineering GmbH
    • Natus Medical Incorporated
    • Compumedics Neuroscan
    • Brain Products GmbH
    • Integra LifeSciences Corporation
    • Advanced Brain Monitoring, Inc.
    • EMOTIV
    • NeuroSky
    • ANT Neuro
    • NIRx Medical Technologies, LLC
    • Ripple Neuro.
    • Neuroelectrics
    • OpenBCI
    • COGNIONICS, INC.（CGX）
    • Blackrock Neurotech
    • Synchron
    • Neurable
Product Code: 978-1-68038-459-8

Brain Computer Interface Market Summary

The global brain computer interface (BCI) market, considering invasive BCIs, the total addressable market (TAM) was estimated at USD 168.27 billion in 2025 and is expected to grow at a CAGR of 1.52% from 2026 to 2033. Several research studies indicate that invasive BCIs offer a higher level of assurance in restoring motor function and communication capabilities in patients with conditions such as Amyotrophic Lateral Sclerosis (ALS), spinal cord injuries, and stroke.

In contrast, considering non-invasive BCIs, the serviceable obtainable market (SOM) was estimated at USD 397.59 million in 2025 and is projected to grow at a CAGR of 8.73% from 2026 to 2033. Key market drivers include the increasing prevalence of conditions requiring neuroprosthetic devices, the rising global geriatric population, and technological advancements that facilitate communication and movement in paralytic patients. Additionally, the expanding use of non-invasive BCIs in home control systems, virtual gaming, and military communication further enhances market applicability, thereby supporting market growth.

BCI technology is primarily utilized in medical and research settings to assist individuals with disabilities in controlling prosthetic limbs or restoring their communication ability. These systems employ electrodes placed on the scalp or implanted in the brain to capture and interpret neural signals, which are then converted into commands for external devices. Recently, advancements in BCI technology have made it more accessible, affordable, and versatile. Consumer-grade BCI devices, such as the Muse and NeuroSky headsets, are available in the market. These headsets utilize wireless dry electrodes that eliminate the need for conductive gel, making them comfortable for users to wear for extended periods. Thus, the availability of such products in the market boosts the market growth.

The increasing prevalence of neurodegenerative disorders is a significant driver of growth in the BCI market. Neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple Sclerosis (MS), are characterized by the progressive degeneration of neurons, leading to a gradual loss of function in the affected areas of the brain and nervous system.

According to the WHO report, around 82 million people will be affected by dementia by 2030 and this number will reach 152 million by 2050. This shows the potential demand for BCI in the coming years. These conditions can severely impact an individual's motor functions, communication abilities, and overall quality of life. As the global population ages, the incidence of these disorders is expected to rise, creating a pressing need for innovative solutions that can help manage symptoms, restore lost functions, and improve the lives of affected individuals.

Global Brain Computer Interface Market Report Segmentation

This report forecasts revenue growth and provides at global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global brain computer interface market report based on product, application, end use, and region:

  • Brain-Computer Interface (BCI) Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Invasive Brain-Computer Interface (BCI) [Total Addressable Market (TAM)]
  • Non Invasive Brain-Computer Interface (BCI) [Serviceable Obtainable Market (SOM)]
  • Invasive Brain-Computer Interface (BCI) Application Outlook :(Revenue in USD Million; 2021 - 2033) [Total Addressable Market (TAM)]
  • MND/ALS
  • Stroke
  • Spinal Cord Injury
  • Multiple Sclerosis Patients
  • Cerebral Palsy
  • Amputation
  • Epilepsy
  • Depression
  • Parkinson's Disease
  • Non Invasive BCI Application Outlook (Revenue in USD Million; 2021 - 2033) [Serviceable Obtainable Market (SOM)]
  • Healthcare
    • Disabilities Restoration
    • Brain Function Repair
  • Smart Home Control
  • Communication and control
  • Entertainment & Gaming
  • Non Invasive BCI End Use Outlook (Revenue in USD Million, 2021 - 2033) [Serviceable Obtainable Market (SOM)]
  • Medical
  • Education & Research
  • Others (Consumer & Wellness, etc.)
  • Non Invasive BCI Regional Outlook (Revenue, USD Million, 2021 - 2033) [Serviceable Obtainable Market (SOM)]
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Brain Computer Interface Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market driver analysis
    • 3.1.2. Market restraint analysis
    • 3.1.3. Market Opportunities
  • 3.2. Brain Computer Interface Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape
    • 3.2.3. Clinical Trial Pipelines in the BCI Technologies
    • 3.2.4. Case Studies

Chapter 4. Invasive Brain-Computer Interface (BCI) Total Addressable Market (TAM) Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Brain Computer Interface Market by Application Outlook
  • 4.4. MND/ALS
    • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5. Stroke
    • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.6. Spinal Cord Injury
    • 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.7. Multiple Sclerosis Patients
    • 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.8. Cerebral Palsy
    • 4.8.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.9. Amputation
    • 4.9.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.10. Epilepsy
    • 4.10.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.11. Depression
    • 4.11.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.12. Parkinson's Disease
    • 4.12.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 5. Non-Invasive Brain Computer Interface Market: Application Estimates & Trend Analysis

  • 5.1. Indication Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Brain Computer Interface Market by Indication Outlook
  • 5.4. Healthcare
    • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.2. Disabilities Restoration
    • 5.4.3. Market estimates and forecast 2021 to 2033 (USD Million)
    • 5.4.4. Brain Function Repair
    • 5.4.5. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Smart Home Control
    • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Communication and control
    • 5.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Entertainment & Gaming
    • 5.7.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Non-Invasive Brain Computer Interface Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Market Share, 2025 & 2033
  • 6.2. Segment Dashboard
  • 6.3. Global Brain Computer Interface Market by End Use Outlook
  • 6.4. Medical
    • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.5. Education & Research
    • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 6.6. Others
    • 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. Non-Invasive Brain Computer Interface Market: Regional Estimates & Trend Analysis, By Type

  • 7.1. Regional Market Share Analysis, 2025 & 2033
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/ reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/ reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/ reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/ reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/ reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/ reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/ reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/ reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/ reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/ reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/ reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/ reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/ reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/ reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Key company market share/position analysis, 2025
  • 8.4. Company Profiles
    • 8.4.1. Medtronic
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Technology Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. G.Tec medical engineering GmbH
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Technology Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Natus Medical Incorporated
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Technology Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Compumedics Neuroscan
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Technology Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Brain Products GmbH
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Technology Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Integra LifeSciences Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Technology Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Advanced Brain Monitoring, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Technology Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. EMOTIV
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Technology Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. NeuroSky
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Technology Type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. ANT Neuro
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Technology Type benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. NIRx Medical Technologies, LLC
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Technology Type benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Ripple Neuro.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Technology Type benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Neuroelectrics
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Technology Type benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. OpenBCI
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Technology Type benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. COGNIONICS, INC. (CGX)
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Technology Type benchmarking
      • 8.4.15.4. Strategic initiatives
    • 8.4.16. Blackrock Neurotech
      • 8.4.16.1. Company overview
      • 8.4.16.2. Financial performance
      • 8.4.16.3. Technology Type benchmarking
      • 8.4.16.4. Strategic initiatives
    • 8.4.17. Synchron
      • 8.4.17.1. Company overview
      • 8.4.17.2. Financial performance
      • 8.4.17.3. Technology Type benchmarking
      • 8.4.17.4. Strategic initiatives
    • 8.4.18. Neurable
      • 8.4.18.1. Company overview
      • 8.4.18.2. Financial performance
      • 8.4.18.3. Technology Type benchmarking
      • 8.4.18.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America brain computer interface market, by region, 2021 - 2033 (USD Million)
  • Table 4 North America brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 10 Canada brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Mexico brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 12 Mexico brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Europe brain computer interface market, by region, 2021 - 2033 (USD Million)
  • Table 14 Europe brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 15 Europe brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 16 Europe brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 17 Germany brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 18 Germany brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 19 Germany brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 20 UK brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 21 UK brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 22 France brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 23 France brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Italy brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 25 Italy brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 26 Spain brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 27 Spain brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Denmark brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 29 Denmark brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 30 Sweden brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 31 Sweden brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 32 Norway brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 33 Norway brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific brain computer interface market, by region, (USD Million) 2021 -
  • Table 35 Asia Pacific brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 36 Asia Pacific brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 37 China brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 38 China brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 39 Japan brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 40 Japan brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 41 India brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 42 India brain computer interface market, by end use, (USD Million) 2021 - 203
  • Table 43 South Korea brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 44 South Korea brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 45 Australia brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 46 Australia brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 47 Thailand brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 48 Thailand brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 49 Latin America brain computer interface market, by region, 2021 - 2033 (USD Million)
  • Table 50 Latin America brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 51 Latin America brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 52 Latin America brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 53 Brazil brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 54 Brazil brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 55 Argentina brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 56 Argentina brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 57 MEA brain computer interface market, by region, 2021 - 2033 (USD Million)
  • Table 58 MEA brain computer interface market, by product, 2021 - 2033 (USD Million)
  • Table 59 MEA brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 60 MEA brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 61 South Africa brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 62 South Africa brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 63 Saudi Arabia brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 64 Saudi Arabia brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 65 UAE brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 66 UAE brain computer interface market, by end use, 2021 - 2033 (USD Million)
  • Table 67 Kuwait brain computer interface market, by application, 2021 - 2033 (USD Million)
  • Table 68 Kuwait brain computer interface market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Brain computer devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 10 Non-invasive BCI segment snapshot
  • Fig. 12 Invasive BCI segment snapshot
  • Fig. 14 Brain computer interface market dynamics
  • Fig. 15 Emerging trends & technologies
  • Fig. 16 Brain computer interface market: PESTLE analysis
  • Fig. 17 Brain computer interface market: Porter's five forces analysis
  • Fig. 18 Non-Invasive Brain computer interface Serviceable Obtainable Market (SOM), Application outlook key takeaways (USD Million)
  • Fig. 19 Non-Invasive Brain computer interface Serviceable Obtainable Market (SOM): Application movement analysis, 2025 & 2033
  • Fig. 20 Healthcare Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Disabilities restoration Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Brain function repair Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Smart home control Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Communication and control Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Entertainment & Gaming Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Non-Invasive Brain computer interface Serviceable Obtainable Market (SOM), End Use outlook key takeaways (USD million)
  • Fig. 27 Non-Invasive Brain computer interface Serviceable Obtainable Market (SOM): End use movement analysis, 2025 & 2033 (USD Million)
  • Fig. 28 Medical market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Education and research Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Others Serviceable Obtainable Market (SOM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Invasive brain computer interface Total Addressable Market (TAM), application outlook key takeaways (USD Billion)
  • Fig. 32 Invasive brain computer interface Total addressable market (TAM): Application movement analysis, 2025 & 2033
  • Fig. 33 MND/ALS Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Stroke Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Spinal cord injury Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Multiple sclerosis Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Cerebral palsy Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Amputation Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Epilepsy Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Depression Total Addressable Market (TAM) estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Non-invasive brain computer interface serviceable obtainable market (SOM), by region
  • Fig. 42 Non-invasive brain computer interface serviceable obtainable market (SOM): Regional marketplace key takeaways (Part 1)
  • Fig. 43 Non-invasive brain computer interface serviceable obtainable market (SOM): Regional marketplace key takeaways (Part 2)
  • Fig. 44 Invasive brain computer interface Total Addressable Market (TAM), by region
  • Fig. 45 North America Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 46 North America Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 U.S. Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Canada Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Mexico Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 53 Europe Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 54 Europe Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 UK: Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Germany Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 France Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Italy Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Spain Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Norway Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Sweden Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Denmark Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 71 Asia Pacific Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 72 Asia Pacific Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Australia Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 South Korea Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 Thailand Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 85 Latin America Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 86 Latin America Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 91 MEA Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 92 MEA Invasive Brain Computer Interface Total Addressable Market (TAM), 2021 - 2033 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Africa Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Saudi Arabia Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Non-invasive Brain Computer Interface Serviceable Obtainable Market (SOM), 2021 - 2033 (USD Million)
  • Fig. 101 Key company categorization
  • Fig. 102 Key company categorization
  • Fig. 103 Y-o-Y funding trends in brain computer interface industry in Millions
  • Fig. 104 Y-o-Y funding rounds in brain computer interface industry
  • Fig. 105 Top Funding Rounds in last 2 years Part I
  • Fig. 106 Top Funding Rounds in last 2 years Part II
  • Fig. 107 Funding by geography in brain computer interface industry in Millions
  • Fig. 108 Y-o-Y stage-wise funding trends in brain computer interface industry in Millions
  • Fig. 109 Y-o-Y stage-wise funding trends in brain computer interface industry (Stage-wise number of rounds)
  • Fig. 110 Y-o-Y number of active investors in brain computer interface industry
  • Fig. 111 Company market position analysis
  • Fig. 112 Strategy mapping